Equities

Astrotech Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Astrotech Corp

Actions
  • Price (EUR)2.36
  • Today's Change0.000 / 0.00%
  • Shares traded1.00k
  • 1 Year change-60.67%
  • Beta0.3835
Data delayed at least 15 minutes, as of Feb 16 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Astrotech Corporation is a spectrometry company, which launches, manages, and commercializes scalable companies based on its core technology. Its business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, and Pro-Control, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology (AMS Technology). 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications.

  • Revenue in USD (TTM)1.31m
  • Net income in USD-14.04m
  • Incorporated2017
  • Employees32.00
  • Location
    Astrotech Corp2105 DONLEY DR. SUITE 100Suite 240-9530AUSTIN 78758United StatesUSA
  • Phone+1 (512) 485-9530
  • Fax+1 (302) 655-5049
  • Websitehttps://www.astrotechcorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.